217330 — Cytogen Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Cytogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,889	-10,871	-18,771	-15,770	-17,116
Depreciation
Amortisation
Non-Cash Items	-717	4,255	10,950	6,553	7,791
Unusual Items
Other Non-Cash Items
Changes in Working Capital	97.3	272	129	-289	-2,293
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-4,466	-5,230	-6,379	-7,594	-9,529
Capital Expenditures	-450	-1,997	-745	-2,622	-1,124
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-3,640	-3,588	-5,909	2,886	-23,225
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-4,090	-5,585	-6,654	263	-24,349
Financing Cash Flow Items	59.7	43.3	14.2	-2.26	28.1
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	9,643	30,027	-1,039	46,236	9,172
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,010	19,212	-14,410	38,960	-24,724